This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Apr;39(4):404-407.

doi: 10.1038/s41587-021-00884-w.

Alternative hosts as the missing link for equitable therapeutic protein production

Joseph R Brady^{1

2}, J Christopher Love^{3

4}

Affiliations

Affiliations

¹ Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
² Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
³ Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. clove@mit.edu.
⁴ Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. clove@mit.edu.

PMID: 33782611
DOI: 10.1038/s41587-021-00884-w

Comment

Alternative hosts as the missing link for equitable therapeutic protein production

Joseph R Brady et al. Nat Biotechnol. 2021 Apr.

. 2021 Apr;39(4):404-407.

doi: 10.1038/s41587-021-00884-w.

Authors

Joseph R Brady^{1

2}, J Christopher Love^{3

4}

Affiliations

¹ Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
² Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
³ Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. clove@mit.edu.
⁴ Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. clove@mit.edu.

PMID: 33782611
DOI: 10.1038/s41587-021-00884-w

No abstract available

PubMed Disclaimer

Comment on

Developing therapeutic monoclonal antibodies at pandemic pace.
Kelley B. Kelley B. Nat Biotechnol. 2020 May;38(5):540-545. doi: 10.1038/s41587-020-0512-5. Nat Biotechnol. 2020. PMID: 32317764 Free PMC article.

References

1. Kelley, B. Nat. Biotechnol. 38, 540–545 (2020). - DOI - PubMed - PMC
1. Hodgson, J. Nat. Biotechnol. https://doi.org/10.1038/d41587-020-00005-z (2020).
1. FDA. Coronavirus Treatment Acceleration Program (CTAP). https://www.fda.gov/drugs/coronavirus-covid-19-drugs/coronavirus-treatme... (2020).
1. Kaplon, H. & Reichert, J. M. MAbs 11, 219–238 (2019). - DOI - PubMed
1. Matthews, C. B. et al. Biotechnol. Bioeng. 114, 2432–2444 (2017). - DOI - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- scite Smart Citations